Skip to main content

Table 2 The overlap between CA125-positive samples (cut-off > 35 IU/mL) and the three DNAme marker panel (using refined new thresholds, see Table 1) in HGS cancer cases and healthy (H)/benign pelvic mass (BPM) controls in serum set 3

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

 

H and BPM

HGS

CA125-negative

CA125-positive

CA125-negative

CA125-positive

3 DNAme marker panel (new thresholds)

Negative

108

18

4

9

Positive

14

0

1

15